-+ 0.00%
-+ 0.00%
-+ 0.00%

Vaccinex Secures $60 Million to Advance Phase 2b Pepinemab Trial for Alzheimer’s Disease

路透·12/23/2025 13:02:00

登錄查看新聞詳情